col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


146 Results       Page 1

 [1] 
MDPI AG: Biomolecules
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―01 Association of Altered Plasma Lipidome with Disease Severity in COVID-19 Patients Zhengzheng Zhang, Naama Karu, Alida Kindt, Madhulika Singh, Lieke Lamont, Adriaan J. van Gammeren, et al. (+8)
2 [GO] 2024―Feb―20 The Binding of the SARS-CoV-2 Spike Protein to Platelet Factor 4: A Proposed Mechanism for the Generation of Pathogenic Antibodies Thi-Huong Nguyen, Li-Yu Chen, Nida Zaman Khan, Annerose Lindenbauer, Van-Chien Bui, Peter F. Zipfel, Doris Heinrich
3 [GO] 2024―Feb―19 Neutrophil Activity and Extracellular Matrix Degradation: Drivers of Lung Tissue Destruction in Fatal COVID-19 Cases and Implications for Long COVID Teluguakula Narasaraju, Indira Neeli, Sheila L. Criswell, Amita Krishnappa, Wenzhao Meng, Vasuki Silva, et al. (+8)
4 [GO] 2024―Jan―19 Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2 Silviya Abarova, Ralitza Alexova, Stela Dragomanova, Ayten Solak, Paolo Fagone, Katia Mangano, et al. (+4)
5 [GO] 2023―Dec―28 An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2 Rosamaria Pennisi, Davide Gentile, Antonio Rescifina, Edoardo Napoli, Paola Trischitta, Anna Piperno, Maria Teresa Sciortino
6 [GO] 2023―Nov―21 A Comparative Analysis of MicroRNA Expression in Mild, Moderate, and Severe COVID-19: Insights from Urine, Serum, and Nasopharyngeal Samples Raya Soltane, Nuha Almulla, Ahlam Alasiri, Nabila F. Elashmawy, Alaa T. Qumsani, Fatimah M. Alshehrei, et al. (+4)
7 [GO] 2023―Nov―17 Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication Ekaterina Knizhnik, Stepan Chumakov, Julia Svetlova, Iulia Pavlova, Yuri Khodarovich, Vladimir Brylev, et al. (+6)
8 [GO] 2023―Nov―07 Low-Entropy Hydration Shells at the Spike RBD’s Binding Site May Reveal the Contagiousness of SARS-CoV-2 Variants Lin Yang, Shuai Guo, Chengyu Hou, Shenda Jiang, Liping Shi, Xiaoliang Ma, et al. (+4)
9 [GO] 2023―Oct―30 Neuroproteomic Analysis after SARS-CoV-2 Infection Reveals Overrepresented Neurodegeneration Pathways and Disrupted Metabolic Pathways Indranil Basak, Rhodri Harfoot, Jennifer E. Palmer, Abhishek Kumar, Miguel E. Quiñones-Mateu, Lucia Schweitzer, Stephanie M. Hughes
10 [GO] 2023―Oct―27 Neuroprotective Agents with Therapeutic Potential for COVID-19 César A. Zaa, Clara Espitia, Karen L. Reyes-Barrera, Zhiqiang An, Marco A. Velasco-Velázquez
11 [GO] 2023―Oct―24 An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines Dona Susan Mathew, Tirtha Pandya, Het Pandya, Yuzen Vaghela, Selvakumar Subbian
12 [GO] 2023―Oct―14 Improved Stability and Manufacturability of Nucleocapsid Antigens for SARS-CoV2 Diagnostics through Protein Engineering Esha Shukla, Lipsa Choudhury, Saurabh Rastogi, Arshmeet Chawla, Sanghati Bhattacharya, Umesh Kaushik, et al. (+3)
13 [GO] 2023―Sep―29 Variations in O-Glycosylation Patterns Influence Viral Pathogenicity, Infectivity, and Transmissibility in SARS-CoV-2 Variants Sherifdeen Onigbinde, Cristian D. Gutierrez Reyes, Mojibola Fowowe, Oluwatosin Daramola, Mojgan Atashi, Andrew I. Bennett, Yehia Mechref
14 [GO] 2023―Sep―27 Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses Ahmed M. Awad, Kamryn Hansen, Diana Del Rio, Derek Flores, Reham F. Barghash, Laura Kakkola, et al. (+2)
15 [GO] 2023―Sep―21 N-Glycome Profile of the Spike Protein S1: Systemic and Comparative Analysis from Eleven Variants of SARS-CoV-2 Cristian D. Gutierrez Reyes, Sherifdeen Onigbinde, Akeem Sanni, Andrew I. Bennett, Peilin Jiang, Oluwatosin Daramola, et al. (+6)
16 [GO] 2023―Sep―13 Rare Variants in Primary Immunodeficiency Genes and Their Functional Partners in Severe COVID-19 Maryam B. Khadzhieva, Dmitry S. Kolobkov, Darya A. Kashatnikova, Alesya S. Gracheva, Ivan V. Redkin, Artem N. Kuzovlev, Lyubov E. Salnikova
17 [GO] 2023―Sep―04 Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives Andrea Citarella, Alessandro Dimasi, Davide Moi, Daniele Passarella, Angela Scala, Anna Piperno, Nicola Micale
18 [GO] 2023―Sep―01 Does SARS-CoV-2 Induce IgG4 Synthesis to Evade the Immune System? Alberto Rubio-Casillas, Elrashdy M. Redwan, Vladimir N. Uversky
19 [GO] 2023―Aug―06 SARS-CoV-2 Infection in Unvaccinated High-Risk Pregnant Women in the Bronx, NY, USA Is Associated with Decreased Apgar Scores and Placental Villous Infarcts Sandra E. Reznik, Patricia M. Vuguin, Alexa Cohen, Rasha Khoury, Olivier Loudig, Ridin Balakrishnan, et al. (+4)
20 [GO] 2023―Jul―10 The Metallodrug BOLD-100 Is a Potent Inhibitor of SARS-CoV-2 Replication and Has Broad-Acting Antiviral Activity Daniel S. Labach, Hinissan P. Kohio, Edwin A. Tse, Ermela Paparisto, Nicole J. Friesen, Jim Pankovich, et al. (+2)
21 [GO] 2023―Jun―26 Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia Maria Antonella Zingaropoli, Tiziana Latronico, Patrizia Pasculli, Giorgio Maria Masci, Roberta Merz, Federica Ciccone, et al. (+12)
22 [GO] 2023―Jun―08 In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Main Protease among a PubChem Database of Avian Infectious Bronchitis Virus 3CLPro Inhibitors Laurent Soulère, Thibaut Barbier, Yves Queneau
23 [GO] 2023―Jun―02 Assessing the Resilience of Machine Learning Classification Algorithms on SARS-CoV-2 Genome Sequences Generated with Long-Read Specific Errors Bikram Sahoo, Sarwan Ali, Pin-Yu Chen, Murray Patterson, Alexander Zelikovsky
24 [GO] 2023―May―03 Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019 Jordan Swiderski, Laura Kate Gadanec, Vasso Apostolopoulos, Graham J. Moore, Konstantinos Kelaidonis, John M. Matsoukas, Anthony Zulli
25 [GO] 2023―Mar―23 Regulation of Epithelial Sodium Transport by SARS-CoV-2 Is Closely Related with Fibrinolytic System-Associated Proteins Tingyu Wang, Yiman Zhai, Hao Xue, Wei Zhou, Yan Ding, Hongguang Nie
26 [GO] 2023―Mar―21 Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice Giovanni Sarnelli, Alessandro Del Re, Marcella Pesce, Jie Lu, Giovanni Esposito, Walter Sanseverino, et al. (+8)
27 [GO] 2023―Mar―06 Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells Marie-Kristin Kroll, Sebastian Schloer, Peynaz Candan, Nadia Korthals, Christoph Wenzel, Hannah Ihle, et al. (+12)
28 [GO] 2023―Feb―16 Metabolic Activation of PARP as a SARS-CoV-2 Therapeutic Target-Is It a Bait for the Virus or the Best Deal We Could Ever Make with the Virus? Is AMBICA the Potential Cure? Prasanth Puthanveetil
29 [GO] 2023―Feb―14 Novel Inhibitory Role of Fenofibric Acid by Targeting Cryptic Site on the RBD of SARS-CoV-2 Jianxiang Huang, Kevin C. Chan, Ruhong Zhou
30 [GO] 2023―Jan―20 SARS-CoV-2 Induces Epithelial-Enteric Neuronal Crosstalk Stimulating VIP Release Arun Balasubramaniam, Philip R. Tedbury, Simon M. Mwangi, Yunshan Liu, Ge Li, Didier Merlin, et al. (+4)
31 [GO] 2023―Jan―13 Combining Semi-Targeted Metabolomics and Machine Learning to Identify Metabolic Alterations in the Serum and Urine of Hospitalized Patients with COVID-19 Gerard Baiges-Gaya, Simona Iftimie, Helena Castañé, Elisabet Rodríguez-Tomàs, Andrea Jiménez-Franco, Ana F. López-Azcona, et al. (+3)
32 [GO] 2023―Jan―09 Genetic Predisposition to Neurological Complications in Patients with COVID-19 Nikhil Shri Sahajpal, Alex R. Hastie, Maximilian Schieck, Ashis K. Mondal, Marc Felde, Caspar I. van der Made, et al. (+9)
33 [GO] 2023―Jan―04 Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients Muhammad Naeem, Naheed Bano, Saba Manzoor, Aftab Ahmad, Nayla Munawar, Saiful Izwan Abd Razak, et al. (+3)
34 [GO] 2023―Jan―02 COVID-19 Pathology Sheds Further Light on Balance between Neutrophil Proteases and Their Inhibitors Vasuki Silva, Marko Radic
35 [GO] 2022―Dec―29 A Computer Simulation of SARS-CoV-2 Mutation Spectra for Empirical Data Characterization and Analysis Ming Xiao, Fubo Ma, Jun Yu, Jianghang Xie, Qiaozhen Zhang, Peng Liu, et al. (+3)
36 [GO] 2022―Dec―27 Heritability of Protein and Metabolite Biomarkers Associated with COVID-19 Severity: A Metabolomics and Proteomics Analysis Amelia K. Haj, Haytham Hasan, Thomas J. Raife
37 [GO] 2022―Dec―21 Metatranscriptomic Analysis Reveals Disordered Alterations in Oropharyngeal Microbiome during the Infection and Clearance Processes of SARS-CoV-2: A Warning for Secondary Infections Yongzhao Zhou, Sifen Lu, Xiaozhen Wei, Ya Hu, Honghao Li, Jing Wang, et al. (+10)
38 [GO] 2022―Dec―12 Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients Adrian Krygier, Dagmara Szmajda-Krygier, Rafał Świechowski, Jacek Pietrzak, Agnieszka Wosiak, Damian Wodziński, Ewa Balcerczak
39 [GO] 2022―Nov―28 Structure-Based Virtual Screening and Functional Validation of Potential Hit Molecules Targeting the SARS-CoV-2 Main Protease Balasubramanian Moovarkumudalvan, Anupriya Madhukumar Geethakumari, Ramya Ramadoss, Kabir H. Biswas, Borbala Mifsud
40 [GO] 2022―Nov―24 SARS-CoV-2 Delta Variant: Interplay between Individual Mutations and Their Allosteric Synergy Kevin C. Chan, Yi Song, Zheng Xu, Chun Shang, Ruhong Zhou
41 [GO] 2022―Nov―23 Identification of Transcriptome Biomarkers for Severe COVID-19 with Machine Learning Methods Xiaohong Li, Xianchao Zhou, Shijian Ding, Lei Chen, Kaiyan Feng, Hao Li, et al. (+2)
42 [GO] 2022―Nov―23 Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV Chenxiao Chen, Hao Liang, Yanchun Deng, Xiushi Yang, Xiaoming Li, Chunsheng Hou
43 [GO] 2022―Nov―14 Subgenomic RNAs and Their Encoded Proteins Contribute to the Rapid Duplication of SARS-CoV-2 and COVID-19 Progression Yifan Zhang, Xinglong Zhang, Huiwen Zheng, Longding Liu
44 [GO] 2022―Nov―14 Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs Lara Massai, Deborah Grifagni, Alessia De De Santis, Andrea Geri, Francesca Cantini, Vito Calderone, et al. (+2)
45 [GO] 2022―Nov―14 Inhibition of SARS-CoV-2 Viral Channel Activity Using FDA-Approved Channel Modulators Independent of Variants Han-Gang Yu, Gina Sizemore, Ivan Martinez, Peter Perrotta
46 [GO] 2022―Nov―11 In Silico Protein Folding Prediction of COVID-19 Mutations and Variants Sumana Bhowmick, Tim Jing, Wei Wang, Elena Y. Zhang, Frank Zhang, Yanmin Yang
47 [GO] 2022―Nov―01 A Pathway Model to Understand the Evolution of Spike Protein Binding to ACE2 in SARS-CoV-2 Variants Ludovico Pipitò, Christopher A. Reynolds, Juan Carlos Mobarec, Owen Vickery, Giuseppe Deganutti
48 [GO] 2022―Oct―24 Renoprotective Effects of Luteolin: Therapeutic Potential for COVID-19-Associated Acute Kidney Injuries Lúcio Ricardo Leite Diniz, Hatem A. Elshabrawy, Marilia Trindade S. Souza, Allana Brunna Sucupira Duarte, Nikhil Madhav, Damião Pergentino de Sousa
49 [GO] 2022―Oct―17 Lipidomics Revealed Plasma Phospholipid Profile Differences between Deceased and Recovered COVID-19 Patients Neven Žarković, Biserka Orehovec, Bruno Baršić, Marko Tarle, Marta Kmet, Ivica Lukšić, et al. (+4)
50 [GO] 2022―Oct―10 COVID-GWAB: A Web-Based Prediction of COVID-19 Host Genes via Network Boosting of Genome-Wide Association Data Seungbyn Baek, Sunmo Yang, Insuk Lee
51 [GO] 2022―Sep―26 A Study on the Nature of SARS-CoV-2 Using the Shell Disorder Models: Reproducibility, Evolution, Spread, and Attenuation Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky
52 [GO] 2022―Sep―26 Elevated Extracellular HSP72 and Blunted Heat Shock Response in Severe COVID-19 Patients Mariana Kras Borges Russo, Lucas Stahlhöfer Kowalewski, Gabriella Richter da Natividade, Carlos Henrique de Lemos Muller, Helena Trevisan Schroeder, Patrícia Martins Bock, et al. (+11)
53 [GO] 2022―Sep―16 The Role of Disordered Regions in Orchestrating the Properties of Multidomain Proteins: The SARS-CoV-2 Nucleocapsid Protein and Its Interaction with Enoxaparin Marco Schiavina, Letizia Pontoriero, Giuseppe Tagliaferro, Roberta Pierattelli, Isabella C. Felli
54 [GO] 2022―Sep―08 SARS-CoV-2 Invasion and Pathological Links to Prion Disease Walter J. Lukiw, Vivian R. Jaber, Aileen I. Pogue, Yuhai Zhao
55 [GO] 2022―Sep―06 t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity Yu Nagayoshi, Kayo Nishiguchi, Ryosuke Yamamura, Takeshi Chujo, Hiroyuki Oshiumi, Hiroko Nagata, et al. (+15)
56 [GO] 2022―Sep―01 SARS-CoV-2 and Skin: New Insights and Perspectives Gerardo Cazzato, Eliano Cascardi, Anna Colagrande, Caterina Foti, Alessandra Stellacci, Maricla Marrone, et al. (+9)
57 [GO] 2022―Aug―25 Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells Guillaume Gerez, Jerome Martinez, Christophe Steinbrugger, Sandra Bouanich, Johanna Dimino, Corine Piegay, et al. (+3)
58 [GO] 2022―Aug―22 Prediction of Potential Commercially Available Inhibitors against SARS-CoV-2 by Multi-Task Deep Learning Model Fan Hu, Jiaxin Jiang, Peng Yin
59 [GO] 2022―Aug―03 CoVM2: Molecular Biological Data Integration of SARS-CoV-2 Proteins in a Macro-to-Micro Method Hongjun Chen, Xiaotian Hu, Yanshi Hu, Jiawen Zhou, Ming Chen
60 [GO] 2022―Aug―01 Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs Nunzio Iraci, Carmelo Corsaro, Salvatore V. Giofrè, Giulia Neri, Angela Maria Mezzasalma, Martina Vacalebre, et al. (+4)
61 [GO] 2022―Aug―01 Targeting the YXXΦ Motifs of the SARS Coronaviruses 1 and 2 ORF3a Peptides by In Silico Analysis to Predict Novel Virus-Host Interactions Athanassios Kakkanas, Eirini Karamichali, Efthymia Ioanna Koufogeorgou, Stathis D. Kotsakis, Urania Georgopoulou, Pelagia Foka
62 [GO] 2022―Jul―28 NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study Laure Morimont, Mélanie Dechamps, Clara David, Céline Bouvy, Constant Gillot, Hélène Haguet, et al. (+9)
63 [GO] 2022―Jul―18 Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing Observations Gaetana Costanza, Pierpaolo Paba, Marco Ciotti, Domenico Ombres, Stefano Di Carlo, Fabbio Marcuccilli, et al. (+14)
64 [GO] 2022―Jul―12 COVID-19 and Parkinsonism: A Critical Appraisal Francesco Cavallieri, Valentina Fioravanti, Francesco Bove, Eleonora Del Prete, Sara Meoni, Sara Grisanti, et al. (+4)
65 [GO] 2022―Jul―12 Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches Aisha Sodagar, Rasab Javed, Hira Tahir, Saiful Izwan Abd Razak, Muhammad Shakir, Muhammad Naeem, et al. (+6)
66 [GO] 2022―Jul―12 Host-Genome Similarity Characterizes the Adaption of SARS-CoV-2 to Humans Weitao Sun
67 [GO] 2022―Jul―11 Integrating Conformational Dynamics and Perturbation-Based Network Modeling for Mutational Profiling of Binding and Allostery in the SARS-CoV-2 Spike Variant Complexes with Antibodies: Balancing Local and Global Determinants of Mutational Escape Mechanisms Gennady Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan
68 [GO] 2022―Jul―05 Saquinavir: From HIV to COVID-19 and Cancer Treatment Mariana Pereira, Nuno Vale
69 [GO] 2022―Jul―02 NMR Reveals Specific Tracts within the Intrinsically Disordered Regions of the SARS-CoV-2 Nucleocapsid Protein Involved in RNA Encountering Letizia Pontoriero, Marco Schiavina, Sophie M. Korn, Andreas Schlundt, Roberta Pierattelli, Isabella C. Felli
70 [GO] 2022―Jun―24 Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19 Xavier Gabaldó, Màrius Juanpere, Helena Castañé, Elisabet Rodríguez-Tomàs, Ana Felisa López-Azcona, Gerard Baiges-Gaya, et al. (+12)
71 [GO] 2022―Jun―14 SCD14-ST and New Generation Inflammatory Biomarkers in the Prediction of COVID-19 Outcome Emanuela Galliera, Luca Massaccesi, Lina Yu, Jianwen He, Marco Ranucci, Massimiliano M. Corsi Romanelli
72 [GO] 2022―Jun―04 Filterability of Erythrocytes in Patients with COVID-19 Dmitry S. Prudinnik, Elena I. Sinauridze, Soslan S. Shakhidzhanov, Elizaveta A. Bovt, Denis N. Protsenko, Alexander G. Rumyantsev, Fazoil I. Ataullakhanov
73 [GO] 2022―May―26 AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2 Bowen Tang, Fengming He, Dongpeng Liu, Fei He, Tong Wu, Meijuan Fang, et al. (+3)
74 [GO] 2022―May―11 Matrix Metalloproteinases in Health and Disease in the Times of COVID-19 Carlos Fernandez-Patron, Eugenio Hardy
75 [GO] 2022―May―11 Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing Pakorn Sagulkoo, Apichat Suratanee, Kitiporn Plaimas
76 [GO] 2022―Apr―26 Shell Disorder Models Detect That Omicron Has Harder Shells with Attenuation but Is Not a Descendant of the Wuhan-Hu-1 SARS-CoV-2 Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky
77 [GO] 2022―Apr―26 COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies Viscardo P. Fabbri, Mattia Riefolo, Tiziana Lazzarotto, Liliana Gabrielli, Giovanna Cenacchi, Carmine Gallo, et al. (+7)
78 [GO] 2022―Apr―20 Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress Pedro V. da Silva-Neto, Valéria B. do Valle, Carlos A. Fuzo, Talita M. Fernandes, Diana M. Toro, Thais F. C. Fraga-Silva, et al. (+31)
79 [GO] 2022―Apr―14 Mutational Effect of Some Major COVID-19 Variants on Binding of the S Protein to ACE2 Zhendong Li, John Z. H. Zhang
80 [GO] 2022―Apr―08 Long COVID-19 in Children: From the Pathogenesis to the Biologically Plausible Roots of the Syndrome Michele Piazza, Maria Di Cicco, Luca Pecoraro, Michele Ghezzi, Diego Peroni, Pasquale Comberiati
81 [GO] 2022―Apr―05 Progress in Assays of HMGB1 Levels in Human Plasma-The Potential Prognostic Value in COVID-19 Michal Štros, Eva Volfová Polanská, Tereza Hlaváčová, Petr Skládal
82 [GO] 2022―Mar―23 The rs8176740 T/A and rs512770 T/C Genetic Variants of the ABO Gene Increased the Risk of COVID-19, as well as the Plasma Concentration Platelets Gilberto Vargas-Alarcón, Julian Ramírez-Bello, Rosalinda Posadas-Sánchez, Gustavo Rojas-Velasco, Alberto López-Reyes, Laura Martínez-Gómez, et al. (+5)
83 [GO] 2022―Mar―22 In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets Federico Ricci, Rosaria Gitto, Giovanna Pitasi, Laura De Luca
84 [GO] 2022―Mar―15 Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation Leslie Chavez-Galan, Andy Ruiz, Karen Martinez-Espinosa, Hiram Aguilar-Duran, Martha Torres, Ramces Falfan-Valencia, et al. (+3)
85 [GO] 2022―Mar―14 Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation Enrique Alfaro, Elena Díaz-García, Sara García-Tovar, Ester Zamarrón, Alberto Mangas, Raúl Galera, et al. (+3)
86 [GO] 2022―Feb―14 Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19 George Vere, Md Rashadul Alam, Sam Farrar, Rachel Kealy, Benedikt M. Kessler, Darragh P. O’Brien, Adán Pinto-Fernández
87 [GO] 2022―Feb―14 Spectrum of Kidney Injury Following COVID-19 Disease: Renal Biopsy Findings in a Single Italian Pathology Service Alessandro Gambella, Antonella Barreca, Luigi Biancone, Dario Roccatello, Licia Peruzzi, Luca Besso, et al. (+4)
88 [GO] 2022―Feb―09 Role of Urinary Kidney Stress Biomarkers for Early Recognition of Subclinical Acute Kidney Injury in Critically Ill COVID-19 Patients Gustavo Casas-Aparicio, Claudia Alvarado-de la Barrera, David Escamilla-Illescas, Isabel León-Rodríguez, Perla Mariana Del Río-Estrada, Natalia Calderón-Dávila, et al. (+9)
89 [GO] 2022―Feb―07 Immunomodulatory Potential of Non-Classical HLA-G in Infections including COVID-19 and Parasitic Diseases Sajad Rashidi, Carmen Vieira, Renu Tuteja, Reza Mansouri, Mohammad Ali-Hassanzadeh, Antonio Muro, et al. (+2)
90 [GO] 2022―Jan―24 Looking at COVID-19 from a Systems Biology Perspective Emily Samuela Turilli, Marta Lualdi, Mauro Fasano
91 [GO] 2022―Jan―06 Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19 Artemio García-Escobar, Silvio Vera-Vera, Alfonso Jurado-Román, Santiago Jiménez-Valero, Guillermo Galeote, Raúl Moreno
92 [GO] 2021―Dec―24 Sex-Related Factors in Cardiovascular Complications Associated to COVID-19 Francesca Megiorni, Paola Pontecorvi, Giulia Gerini, Eleni Anastasiadou, Cinzia Marchese, Simona Ceccarelli
93 [GO] 2021―Dec―03 The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression Mariano Maffei, Linda Celeste Montemiglio, Grazia Vitagliano, Luigi Fedele, Shaila Sellathurai, Federica Bucci, et al. (+7)
94 [GO] 2021―Oct―28 Glycan Epitopes and Potential Glycoside Antagonists of DC-SIGN Involved in COVID-19: In Silico Study Meina Gao, Hui Li, Chenghao Ye, Kaixian Chen, Hualiang Jiang, Kunqian Yu
95 [GO] 2021―Oct―20 Mechanisms of Immunothrombosis by SARS-CoV-2 María Teresa Hernández-Huerta, Alma Dolores Pérez-Santiago, Laura Pérez-Campos Mayoral, Luis Manuel Sánchez Navarro, Francisco Javier Rodal Canales, Abraham Majluf-Cruz, et al. (+7)
96 [GO] 2021―Oct―11 Shortening Epitopes to Survive: The Case of SARS-CoV-2 Lambda Variant Stefano Pascarella, Massimo Ciccozzi, Martina Bianchi, Domenico Benvenuto, Marta Giovanetti, Roberto Cauda, Antonio Cassone
97 [GO] 2021―Sep―28 Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course Michał Kukla, Tomasz Menżyk, Marcin Dembiński, Marek Winiarski, Aleksander Garlicki, Monika Bociąga-Jasik, et al. (+13)
98 [GO] 2021―Sep―18 The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic Maryam Azimzadeh, Nora Möhn, Sajjad Ghane Ezabadi, Zahra Moghimi Esfandabadi, Alireza Soleimani, Elaheh Ranjbar, et al. (+4)
99 [GO] 2021―Sep―17 Further Findings Concerning Endothelial Damage in COVID-19 Patients Monica Gelzo, Sara Cacciapuoti, Biagio Pinchera, Annunziata De Rosa, Gustavo Cernera, Filippo Scialò, et al. (+7)
100 [GO] 2021―Sep―15 Bioguided Isolation of Cyclopenin Analogues as Potential SARS-CoV-2 Mpro Inhibitors from Penicillium citrinum TDPEF34 Bathini Thissera, Ahmed M. Sayed, Marwa H. A. Hassan, Sayed F. Abdelwahab, Ngozi Amaeze, Valeria T. Semler, et al. (+5)
101 [GO] 2021―Aug―26 Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency Ahmed L. Alaofi, Mudassar Shahid
102 [GO] 2021―Aug―20 Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant Priya Antony, Ranjit Vijayan
103 [GO] 2021―Aug―17 HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study Gerardo Cazzato, Anna Colagrande, Antonietta Cimmino, Gerolamo Cicco, Vincenza Sara Scarcella, Paola Tarantino, et al. (+10)
104 [GO] 2021―Aug―13 Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women Aleksandra Obuchowska, Arkadiusz Standyło, Karolina Obuchowska, Żaneta Kimber-Trojnar, Bożena Leszczyńska-Gorzelak
105 [GO] 2021―Aug―02 Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19-A Preliminary Study Beata Kuśnierz-Cabala, Barbara Maziarz, Paulina Dumnicka, Marcin Dembiński, Maria Kapusta, Monika Bociąga-Jasik, et al. (+4)
106 [GO] 2021―Jul―30 Relevance of BET Family Proteins in SARS-CoV-2 Infection Nieves Lara-Ureña, Mario García-Domínguez
107 [GO] 2021―Jul―28 Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2 Raquel Arroyo, Shawn N. Grant, Miriam Colombo, Lucia Salvioni, Fabio Corsi, Marta Truffi, et al. (+5)
108 [GO] 2021―Jul―20 Adventitial Microcirculation Is a Major Target of SARS-CoV-2-Mediated Vascular Inflammation Francesco Vasuri, Carmen Ciavarella, Salvatore Collura, Chiara Mascoli, Sabrina Valente, Alessio Degiovanni, et al. (+3)
109 [GO] 2021―Jul―19 Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays Fulvio Perrella, Federico Coppola, Alessio Petrone, Chiara Platella, Daniela Montesarchio, Annarita Stringaro, et al. (+4)
110 [GO] 2021―Jul―13 COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street? Kenneth Lundstrom, Debmalya Barh, Bruce D. Uhal, Kazuo Takayama, Alaa A. A. Aljabali, Tarek Mohamed Abd El-Aziz, et al. (+20)
111 [GO] 2021―Jul―06 COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies Renuka Raman, Krishna J. Patel, Kishu Ranjan
112 [GO] 2021―Jul―05 Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers-Relevance to COVID-19 Graham J. Moore, Jose M. Pires, Konstantinos Kelaidonis, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, John M. Matsoukas
113 [GO] 2021―Jun―22 Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type Anwar Mohammad, Fahd Al-Mulla, Dong-Qing Wei, Jehad Abubaker
114 [GO] 2021―Jun―18 Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19 Saadullah Khattak, Mohd Ahmar Rauf, Qamar Zaman, Yasir Ali, Shabeen Fatima, Pir Muhammad, et al. (+6)
115 [GO] 2021―Jun―14 Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk Sara Chiappalupi, Laura Salvadori, Rosario Donato, Francesca Riuzzi, Guglielmo Sorci
116 [GO] 2021―Jun―08 Can Antiviral Activity of Licorice Help Fight COVID-19 Infection? Luisa Diomede, Marten Beeg, Alessio Gamba, Oscar Fumagalli, Marco Gobbi, Mario Salmona
117 [GO] 2021―Jun―07 SARS-CoV-2 and Skin: The Pathologist’s Point of View Gerardo Cazzato, Giulia Mazzia, Antonietta Cimmino, Anna Colagrande, Sara Sablone, Teresa Lettini, et al. (+10)
118 [GO] 2021―May―28 Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases Dakshinamurthy Sivakumar, Matthias Stein
119 [GO] 2021―May―26 Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia Francesca Lunardi, Francesco Fortarezza, Luca Vedovelli, Federica Pezzuto, Annalisa Boscolo, Marco Rossato, et al. (+7)
120 [GO] 2021―May―24 Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement Mathew A. Coban, Juliet Morrison, Sushila Maharjan, David Hyram Hernandez Medina, Wanlu Li, Yu Shrike Zhang, et al. (+6)
121 [GO] 2021―May―06 Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps Brandon Bautista-Becerril, Rebeca Campi-Caballero, Samuel Sevilla-Fuentes, Laura M. Hernández-Regino, Alejandro Hanono, Al Flores-Bustamante, et al. (+6)
122 [GO] 2021―Apr―29 Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm Seth O. Asiedu, Samuel K. Kwofie, Emmanuel Broni, Michael D. Wilson
123 [GO] 2021―Apr―27 Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach Marie-Thérèse Hopp, Daniel Domingo-Fernández, Yojana Gadiya, Milena S. Detzel, Regina Graf, Benjamin F. Schmalohr, et al. (+3)
124 [GO] 2021―Apr―20 SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors Andrea Citarella, Angela Scala, Anna Piperno, Nicola Micale
125 [GO] 2021―Apr―20 Protein Intrinsic Disorder and Evolvability of MERS-CoV Vladimir N. Uversky, Elrashdy M. Redwan, Abdullah A. Aljadawi
126 [GO] 2021―Apr―14 Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2 Anwar Mohammad, Eman Alshawaf, Sulaiman K. Marafie, Mohamed Abu-Farha, Fahd Al-Mulla, Jehad Abubaker
127 [GO] 2021―Mar―19 Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19) Amr El-Demerdash, Ahmed M. Metwaly, Afnan Hassan, Tarek Mohamed Abd El-Aziz, Eslam B. Elkaeed, Ibrahim H. Eissa, et al. (+2)
128 [GO] 2021―Mar―15 COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August-October 2020 Francesca Colavita, Francesco Vairo, Silvia Meschi, Maria Beatrice Valli, Eleonora Lalle, Concetta Castilletti, et al. (+9)
129 [GO] 2021―Mar―09 Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for Future Outbreaks Murat Seyran, Sk. Sarif Hassan, Vladimir N. Uversky, Pabitra Pal Choudhury, Bruce D. Uhal, Kenneth Lundstrom, et al. (+15)
130 [GO] 2021―Mar―08 Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis Eugenio Hardy, Carlos Fernandez-Patron
131 [GO] 2021―Feb―22 Screening and Molecular Modeling Evaluation of Food Peptides to Inhibit Key Targets of COVID-19 Virus Ai-Min Shi, Rui Guo, Qiang Wang, Jin-Rong Zhou
132 [GO] 2021―Feb―18 Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages Umesh Kalathiya, Monikaben Padariya, Robin Fahraeus, Soumyananda Chakraborti, Ted R. Hupp
133 [GO] 2021―Feb―04 In Silico Screening of Natural Products Isolated from Mexican Herbal Medicines against COVID-19 Nadia A. Rivero-Segura, Juan C. Gomez-Verjan
134 [GO] 2021―Jan―31 Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection Hao Sun, Xiaojuan Su, Lingyi Huang, Dezhi Mu, Yi Qu
135 [GO] 2021―Jan―13 Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm Alexandra Pum, Maria Ennemoser, Tiziana Adage, Andreas J. Kungl
136 [GO] 2021―Jan―08 Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies Lúcio Ricardo Leite Diniz, Yunierkis Perez-Castillo, Hatem A. Elshabrawy, Carlos da Silva Maia Bezerra Filho, Damião Pergentino de Sousa
137 [GO] 2020―Dec―31 Potential Medicinal Plants for the Treatment of Dengue Fever and Severe Acute Respiratory Syndrome-Coronavirus Mohammed S. M. Saleh, Yusof Kamisah
138 [GO] 2020―Dec―28 A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease Alejandro Llanes, Héctor Cruz, Viet D. Nguyen, Oleg V. Larionov, Patricia L. Fernández
139 [GO] 2020―Dec―14 Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs Ainhoa Moliner-Morro, Daniel J. Sheward, Vivien Karl, Laura Perez Vidakovics, Ben Murrell, Gerald M. McInerney, Leo Hanke
140 [GO] 2020―Oct―16 A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool German Todorov, Vladimir N. Uversky
141 [GO] 2020―Sep―21 Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues Ognjen Perišić
142 [GO] 2020―Sep―14 Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics? Fatma Elrashdy, Elrashdy M. Redwan, Vladimir N. Uversky
143 [GO] 2020―Aug―12 Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) Mahir Karakas, Dominik Jarczak, Martin Becker, Kevin Roedl, Marylyn M. Addo, Frauke Hein, et al. (+7)
144 [GO] 2020―Jun―24 Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis Joseph T. Ortega, Maria Luisa Serrano, Beata Jastrzebska
145 [GO] 2020―Mar―02 Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63 Yu-Chi Tsai, Chia-Lin Lee, Hung-Rong Yen, Young-Sheng Chang, Yu-Ping Lin, Su-Hua Huang, Cheng-Wen Lin
146 [GO] 2020―Feb―21 Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky
 [1] 

146 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec